Welcome to Alcinous Pharmaceuticals

Alcinous strives to produce innovative therapies for a variety of oncology purposes using a computational approach.

Fog and Nature
 

Who We Are

Innovators

We strive to design and develop therapeutics for aggressive cancers. Founded in 2016 by three PhD students at the University of Rhode Island, Alcinous Pharmaceuticals uses a novel drug discovery pipeline in tandem with their innovative team to develop new classes of therapeutics.

 

Our Technology

Novel Interactions with Therapeutic Targets

At Alcinous Pharmaceuticals, we design and develop new molecules that modulate the activity of well-established protein targets related to oncology and other pathologies. Our computational and synthetic approaches facilitate the identification and development of novel target ligands and new therapeutics.

 

DNA Repair Proteins

Inhibitors targeting DNA repair are a rapidly expanding class of oncology drugs.  Here at Alcinous, we have designed new classes of inhibitors in an effort to reduce toxicity, increase effectiveness, and improve patient outcomes.

 

Meet The Team

Who We Are

Nicholas DaSilva, Ph.D.

Chief Executive Officer

Kenneth N. Rose, Ph.D.

Chief Scientific Officer

Benjamin Barlock, Ph.D.

Chief Technology Officer

David Worthen, J.D., Ph.D.

Chief Operations Officer

 

Media & Press Updates

What’s Happening

URI sweeps latest round of state Innovation Voucher grants

November 7, 2017

KINGSTON, R.I, November 07, 2017 — Experts at the University of Rhode Island have been named partners in all three of the latest Innovation Vouchers awarded by the Rhode Island Commerce Corp. And in one case, the small business partnering with the University is led by URI graduate students... continue reading

Campus business in drug research

October 13, 2017

Fed up with the “status quo” in the pharmaceutical industry and inspired by the “endless possibilities” in drug development, current University of Rhode Island College of Pharmacy Ph.D. students Kenneth Rose, Nicholas DaSilva and Benjamin Barlock launched Alcinous Pharmaceuticals last December. The human body “is one giant puzzle,” said Rose of the URI-based company’s challenge.… continue reading

URI Students Launch Pharmaceutical Company

June 9, 2017

Anyone who has known a cancer patient knows that treatments can be difficult.  Three PhD students at URI are trying to help. They're working to develop potential new medications.  They’re grad students by day and executives by night... continue reading

URI graduate students launch pharmaceutical company

June 6, 2017

Three Ph.D. students at the University of Rhode Island’s College of Pharmacy have started a company that harnesses big data in a novel approach to drug development... continue reading

We always have a story to tell, to check our news section often and contact us if you need more information!

 

Contact

We’re happy to hear from you. Contact us today to learn more about our business.

Phone:

401-433-9603

 

©2017 BY ALCINOUS PHARMACEUTICALS. PROUDLY CREATED WITH WIX.COM